Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Post-Marketing Observational Study of the Safety of Roflumilast

NCT03381573 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03381573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03381573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Post-Marketing Observational Study of the Safety of Roflumilast
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 15, 2013
Completion date
September 16, 2022
Enrollment
135,856 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

copd